Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wentao Lu

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Ecology and Evolution|March 9, 2026
A Dangerous Prey Fish? <i>Brachyspira</i>-Rich Gastrointestinal Microbiota in Pompano Dolphinfish From Neritic and Deep Waters of the South China SeaWentao Lu, Xinrui Long, Liang Fang, et al.
Trends in Biotechnology|April 12, 2026
A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNAJieyu Cui, Lulu Zhang, Jing Zhou, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 21, 2019
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN StudyAlex C Spyropoulos, Concetta Lipardi, Jianfeng Xu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 21, 2026
Enhancing Efficiency and Stability of Organic Solar Cells via Amide-Functionalized UV Down-ConvertersWentao Lu, Mingfei Li, Tongyu Ju, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 1, 2021
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With BronchiectasisConcetta Lipardi, C Gregory Elliott, Chiara L Sugarmann, et al.
Thrombosis and Haemostasis|January 25, 2020
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER TrialsJeffrey I Weitz, Gary E Raskob, Alex C Spyropoulos, et al.
Food Research International (Ottawa, Ont.)|February 11, 2024
Mechanisms by which sheep milk consumption ameliorates insulin resistance in high-fat diet-fed miceLei Zhang, Jiaxin Liu, Yongliang Wang, et al.
Journal of the American Heart Association|February 15, 2021
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical PatientsGary E Raskob, Alex C Spyropoulos, Alexander T Cohen, et al.
Journal of the American Heart Association|September 24, 2021
Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE StudyBrian W McCrindle, Alan D Michelson, Andrew H Van Bergen, et al.
Journal of the American College of Cardiology|June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill PatientsAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Ecology and Evolution|March 9, 2026
A Dangerous Prey Fish? <i>Brachyspira</i>-Rich Gastrointestinal Microbiota in Pompano Dolphinfish From Neritic and Deep Waters of the South China SeaWentao Lu, Xinrui Long, Liang Fang, et al.
Trends in Biotechnology|April 12, 2026
A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNAJieyu Cui, Lulu Zhang, Jing Zhou, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 21, 2019
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN StudyAlex C Spyropoulos, Concetta Lipardi, Jianfeng Xu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 21, 2026
Enhancing Efficiency and Stability of Organic Solar Cells via Amide-Functionalized UV Down-ConvertersWentao Lu, Mingfei Li, Tongyu Ju, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 1, 2021
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With BronchiectasisConcetta Lipardi, C Gregory Elliott, Chiara L Sugarmann, et al.
Thrombosis and Haemostasis|January 25, 2020
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER TrialsJeffrey I Weitz, Gary E Raskob, Alex C Spyropoulos, et al.
Food Research International (Ottawa, Ont.)|February 11, 2024
Mechanisms by which sheep milk consumption ameliorates insulin resistance in high-fat diet-fed miceLei Zhang, Jiaxin Liu, Yongliang Wang, et al.
Journal of the American Heart Association|February 15, 2021
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical PatientsGary E Raskob, Alex C Spyropoulos, Alexander T Cohen, et al.
Journal of the American Heart Association|September 24, 2021
Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE StudyBrian W McCrindle, Alan D Michelson, Andrew H Van Bergen, et al.
Journal of the American College of Cardiology|June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill PatientsAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Pageof 5